Verano Holdings (VRNO) Current Taxes (2021 - 2026)
Verano Holdings' (VRNO) quarterly Current Taxes came in at $11.3 million in Q1 2026, down 67.65% year-on-year from $35.0 million in Q1 2025, and down 6.7% on a QoQ basis from $12.1 million in Q4 2025.
Verano Holdings (VRNO) Current Taxes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Current Taxes data on file, last reported at $11.3 million in Q1 2026.
- On a quarterly basis, Current Taxes fell 67.65% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 67.65% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, down 81.03% from the prior year.
- Current Taxes for Q1 2026 stood at $11.3 million, down from $12.1 million in the prior quarter.
- Over the last five years, Current Taxes for VRNO reached as high as $285.3 million in Q3 2024 and fell as low as -$23.1 million in Q1 2022.
- Historically, Current Taxes has averaged $150.0 million across 5 years, with a median of $222.3 million in 2022.
- Across the five-year window, Current Taxes jumped 38082.33% in 2022 and plunged 94.97% in 2025, its largest moves.
- Year by year, Current Taxes stood at $252.8 million in 2022, then declined by 1.7% to $248.5 million in 2023, then sank by 74.28% to $63.9 million in 2024, then slumped by 81.03% to $12.1 million in 2025, then retreated by 6.7% to $11.3 million in 2026.
- Per Business Quant data, the three most recent Current Taxes figures were $11.3 million in Q1 2026, $12.1 million in Q4 2025, and $14.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Sep 30, 2025 | 14.34 Mn |
| Jun 30, 2025 | 31.31 Mn |
| Mar 31, 2025 | 34.96 Mn |
| Dec 31, 2024 | 63.91 Mn |
| Sep 30, 2024 | 285.27 Mn |
| Jun 30, 2024 | 251.24 Mn |
| Mar 31, 2024 | 258.07 Mn |
| Dec 31, 2023 | 248.47 Mn |
| Sep 30, 2023 | 251.00 Mn |
| Jun 30, 2023 | 227.09 Mn |
| Mar 31, 2023 | 247.75 Mn |
| Dec 31, 2022 | 252.77 Mn |
| Sep 30, 2022 | 222.32 Mn |
| Jun 30, 2022 | 161.43 Mn |
| Mar 31, 2022 | -23.07 Mn |
| Dec 31, 2021 | 662,000.00 |